VitusCare raises $3.21M Series B to expand dialysis network
What's the deal? Indian dialysis care startup VitusCareDealroom has a profile for this one. Try Dealroom → has raised nearly US$4.07M in a Series B round. Investors included Singapore-based Liberty Ridge Capital, HDFC BankDealroom has a profile for this one. Try Dealroom →, EquentisDealroom has a profile for this one. Try Dealroom →, NAFA Capital Advisors, and existing backers 1CrowdDealroom has a profile for this one. Try Dealroom → and 3i PartnersDealroom has a profile for this one. Try Dealroom →.
What's the endgame? The Gurugram-based company runs dialysis services through a capital-light "shop-in-shop" model, placing specialised care inside existing hospitals rather than building standalone facilities. It will use the capital for network expansion, technology development, and workforce training, including a Technician Academy to build a pipeline of skilled staff.
The numbers: VitusCare reported revenue of around US$5.98M in FY26 and is targeting nearly US$8.83M in FY27. Its network has grown from 22 to more than 60 centres across nine states, treating over 35,000 patients. It previously raised US$1.36M in 2020 and US$2.99M in mid-2024 in a round led by Tomorrow CapitalDealroom has a profile for this one. Try Dealroom →.
The expansion: The company plans to grow beyond 100 centres by the end of FY27 and is exploring opportunities in select Asian markets.
Why now? India's National Dialysis Programme now spans 751 districts, but a parliamentary committee has flagged shortages of trained staff and operational challenges. VitusCare's hospital-partnered model is a bet on closing that gap in underserved areas.
"We are focused on building a sustainable dialysis care model that combines clinical excellence with operational efficiency," said founder and chief executive officer Prabhat Shrivastava.
The signal: The raise is modest against bigger players — NephroPlus pulled in $102 million from Quadria CapitalDealroom has a profile for this one. Try Dealroom → in 2024 — but it reflects sustained investor interest in Indian dialysis care. VitusCare's challenge will be scaling access past 100 centres while holding care standards steady.
Read more: business-standard.com
Image credit: "Patient receiving dialysis" by shanelkalicharan, licensed under CC BY-SA 2.0